Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
作者信息
Johnston Sebastian L
机构信息
National Heart and Lung Institute, Imperial College London, London, UK.
出版信息
Allergy. 2020 Jul;75(7):1543-1545. doi: 10.1111/all.14348.
Abstract
摘要
相似文献
1
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Allergy. 2020 Jul;75(7):1543-1545. doi: 10.1111/all.14348.
2
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Arq Bras Cardiol. 2020 Jun;114(6):1061-1066. doi: 10.36660/abc.20200389. Epub 2020 Jul 3.
3
COVID-19, severe asthma, and biologics.
Ann Allergy Asthma Immunol. 2020 Sep;125(3):357-359.e1. doi: 10.1016/j.anai.2020.06.012. Epub 2020 Jun 14.
4
Impact of the COVID-19 pandemic in children with allergic asthma.
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3172-3174.e1. doi: 10.1016/j.jaip.2020.07.019. Epub 2020 Jul 27.
5
Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?
Circ J. 2020 Sep 25;84(10):1887. doi: 10.1253/circj.CJ-20-0462. Epub 2020 Aug 7.
6
Is the type of diabetes treatment relevant to outcome of COVID-19?
J Diabetes. 2020 Jul;12(7):486-487. doi: 10.1111/1753-0407.13047.
7
COVID-19 update: Covid-19-associated coagulopathy.
J Thromb Thrombolysis. 2020 Jul;50(1):54-67. doi: 10.1007/s11239-020-02134-3.
8
Reactivation of COVID-19 pneumonia: A report of two cases.
J Infect. 2020 Aug;81(2):e72-e73. doi: 10.1016/j.jinf.2020.05.008. Epub 2020 May 7.
9
The potential role of nanomedicine on COVID-19 therapeutics.
Ther Deliv. 2020 Jul;11(7):411-414. doi: 10.4155/tde-2020-0069. Epub 2020 Jun 29.
10
Association of asthma and its genetic predisposition with the risk of severe COVID-19.
J Allergy Clin Immunol. 2020 Aug;146(2):327-329.e4. doi: 10.1016/j.jaci.2020.06.001. Epub 2020 Jun 6.
引用本文的文献
1
Socio-demographic environmental and clinical factors influencing asthma control in community pharmacies of Lahore Pakistan.
Sci Rep. 2025 Mar 27;15(1):10587. doi: 10.1038/s41598-025-95373-4.
2
The interpretation of COVID-19 in cause-of-death statistics: a matter of causality.
GMS Infect Dis. 2024 Sep 11;12:Doc02. doi: 10.3205/id000087. eCollection 2024.
3
Impact of the COVID-19 Pandemic on Hospital Admission Rate, Length of Stay, and Mortality Rate for Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Retrospective Study.
J Community Hosp Intern Med Perspect. 2024 Mar 4;14(2):1-8. doi: 10.55729/2000-9666.1311. eCollection 2024.
4
A systematic two-sample and bidirectional MR process highlights a unidirectional genetic causal effect of allergic diseases on COVID-19 infection/severity.
J Transl Med. 2024 Jan 23;22(1):94. doi: 10.1186/s12967-024-04887-4.
5
Asthma May Not be a Potential Risk Factor for Severe COVID-19 Illness: A Scoping Review.
Environ Health Insights. 2024 Jan 3;18:11786302231221925. doi: 10.1177/11786302231221925. eCollection 2024.
6
Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes.
BMJ Open Respir Res. 2024 Jan 6;11(1):e001874. doi: 10.1136/bmjresp-2023-001874.
7
Asthma and COPD as co-morbidities in patients hospitalised with Covid-19 disease: a global systematic review and meta-analysis.
BMC Pulm Med. 2023 Nov 22;23(1):462. doi: 10.1186/s12890-023-02761-5.
8
Implementing a Multidisciplinary Post-COVID Clinic in a Small Community Environment.
Arch Rehabil Res Clin Transl. 2023 Jul 26;5(3):100270. doi: 10.1016/j.arrct.2023.100270. eCollection 2023 Sep.
9
Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis.
Vaccines (Basel). 2022 Dec 30;11(1):89. doi: 10.3390/vaccines11010089.
10
Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma.
Front Immunol. 2022 Sep 23;13:988479. doi: 10.3389/fimmu.2022.988479. eCollection 2022.
本文引用的文献
1
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics.
Pediatr Allergy Immunol. 2020 Jul;31(5):442-448. doi: 10.1111/pai.13262. Epub 2020 May 31.
2
Advanced forecasting of SARS-CoV-2-related deaths in Italy, Germany, Spain, and New York State.
Allergy. 2020 Jul;75(7):1813-1815. doi: 10.1111/all.14327. Epub 2020 May 11.
3
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
4
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2.
Allergy. 2020 Jul;75(7):1809-1812. doi: 10.1111/all.14316. Epub 2020 Apr 27.
5
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Lancet. 2020 Apr 4;395(10230):1111. doi: 10.1016/S0140-6736(20)30691-7. Epub 2020 Mar 24.
6
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
7
Eleven faces of coronavirus disease 2019.
Allergy. 2020 Jul;75(7):1699-1709. doi: 10.1111/all.14289. Epub 2020 Apr 6.
8
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
9
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
Lancet. 2017 Aug 12;390(10095):659-668. doi: 10.1016/S0140-6736(17)31281-3. Epub 2017 Jul 4.
10
Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.
J Antimicrob Chemother. 2016 Oct;71(10):2767-81. doi: 10.1093/jac/dkw222. Epub 2016 Jul 25.
Zotero 插件